The shares of newly listed companies — Krsnaa Diagnostics, Exxaro Tiles, and Windlas Biotech — ended mixed and all witnessed a marginal profit booking on the first day of listing on Monday.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

In the early morning trade, Krsnaa and Exxaro had muted start on the exchanges, while Windlas fell by around 10 per cent at the time of listing. The only stock that had a significant listing was Devyani International. This stock listed at a premium of over 55 per cent from its issue price.

See Zee Business Live TV Streaming Below:

Krsnaa concluded its first trading session by around 3.34 per cent lower to Rs 990.75 per share on the BSE. The stock was listed at around 6 per cent higher premium to Rs 1010 apiece on NSE and Rs 1016 apiece on BSE, as against Rs 954 a share at the upper end of issue price.

The counter hit a high of Rs 1099.5 per share and a low of Rs 961.45 per share on the BSE in the intraday trade today.

Similarly, Exxaro Tiles shares ended positively by almost 5 per cent gain to Rs 132.25 per share on the BSE. The stock got listed by over 10 per cent higher premium above Rs 132 per share on BSE and NSE from Rs 120 per share at the upper end of the issue price.

For Krsnaa Diagnostics and Exxaro Tiles, Zee Business Managing Editor Anil Singhvi had predicted that the former may get listed between Rs 1150-1200 per share range, while the latter shall start its bourses journey near issue price at Rs 120 per share.

Whereas, the shares of Windlas Biotech on the first day of its trading session ended weak by over 7 per cent to Rs 406.7 per share, below issue price of Rs 460 per share at the upper end. The stock earlier today got listed at around 10 per cent lower to Rs 419 per share on both BSE and NSE.

The counter missed the managing editor’s expectations that it would be listed in a range of Rs 500-550 per share.